APA

Lejeune F., Liénard D., Eggermont A., Schraffordt Koops H., Rosenkaimer F., Gérain J., Klaase J., Kroon B. & Schmitz P. (19951030). [Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience]. : Bulletin du cancer.

Chicago

Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B and Schmitz P. 19951030. [Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience]. : Bulletin du cancer.

Harvard

Lejeune F., Liénard D., Eggermont A., Schraffordt Koops H., Rosenkaimer F., Gérain J., Klaase J., Kroon B. and Schmitz P. (19951030). [Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience]. : Bulletin du cancer.

MLA

Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B and Schmitz P. [Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience]. : Bulletin du cancer. 19951030.